The objective of this survey was to determine both the nature and extent of regulatory hurdles experienced by companies in seeking Market Authorisation for medicines in African countries. The target groups for the survey were the PIASA Export working group and the PIASA Regulatory working group. Specific commercial issues were avoided for reasons of Competition Law...